![17-(Cyclopropylmethyl)-4'',4'',5'',5''-tetramethyl-4'',5''dihydro-(7betaH)-6alpha,14-ethano-(5betaH)-difurano[2',3',4',5':4,12,13,5;2'',3'':6,7]-14alpha-morphinan-3-ol](https://static.cymitquimica.com/products/86/img/MM0120.02-0025.png "Click to enlarge")
17-(Cyclopropylmethyl)-4'',4'',5'',5''-tetramethyl-4'',5''dihydro-(7betaH)-6alpha,14-ethano-(5betaH)-difurano[2',3',4',5':4,12,13,5;2'',3'':6,7]-14alpha-morphinan-3-ol
CAS: 89663-73-0
Ref. 86-MM0120.02-0025
| 25mg | 1,334.00 € |
Estimated delivery in United States, on Tuesday 11 Jun 2024
Product Information
Name:
17-(Cyclopropylmethyl)-4'',4'',5'',5''-tetramethyl-4'',5''dihydro-(7betaH)-6alpha,14-ethano-(5betaH)-difurano[2',3',4',5':4,12,13,5;2'',3'':6,7]-14alpha-morphinan-3-ol
Controlled Product
Synonyms:
- 8a,12a-Ethano-4,8-methano-12bH-benzofuro[3,2-e]furo[2,3-g]isoquinolin-1-ol
- 7-(cyclopropylmethyl)-5,6,7,8,9,9a,10,11-octahydro-10,10,11,11-tetramethyl-
- (4bS,8R,8aS,9aR,12aR,12bR)- (9CI)
- Buprenorphine Imp. I (EP)
CAS:
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Mikromol
Long term storage:
Notes:
Chemical properties
Molecular weight:
435.60
Formula:
C28H37NO3
Color/Form:
Neat
InChI:
InChI=1S/C28H37NO3/c1-24(2)19-14-26-9-10-28(19,32-25(24,3)4)23-27(26)11-12-29(15-16-5-6-16)20(26)13-17-7-8-18(30)22(31-23)21(17)27/h7-8,16,19-20,23,30H,5-6,9-15H2,1-4H3/t19-,20-,23-,26-,27+,28-/m1/s1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 86-MM0120.02-0025 17-(Cyclopropylmethyl)-4'',4'',5'',5''-tetramethyl-4'',5''dihydro-(7betaH)-6alpha,14-ethano-(5betaH)-difurano[2',3',4',5':4,12,13,5;2'',3'':6,7]-14alpha-morphinan-3-ol
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
